Home
News
Create
Screeners
Insights
Earkart
122.
00
+1.00
(+0.83%)
Market Cap
₹167.78 Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.83%
1M
-17.96%
6M
-14.24%
1Y
-14.24%
5Y
-14.24%
View Company Insights
Latest news about Earkart
Earkart Limited Completes Postal Ballot Notice Dispatch for IPO Proceeds Reallocation
1 day ago
Earkart Limited has completed the dispatch of its postal ballot notice through newspaper advertisements in Financial Express and Jansatta, seeking shareholder approval to reallocate ₹1304.69 lakhs from its IPO proceeds towards new pharmaceutical initiatives and strategic acquisitions. The e-voting process runs from April 02 to May 01, 2026, requiring approval from more than 90% of voting shareholders.
Earkart Limited Appoints M/s. Arvind Aggarwal & Associates as Internal Auditor for FY 2025-26
4 days ago
Earkart Ltd Schedules Board Meeting on March 30, 2026 to Review IPO Proceeds Utilization
Mar 20, 2026
Earkart Limited Board Approves Land Acquisition and Pharmaceutical Business Expansion
Mar 11, 2026
Earkart Limited Incorporates US Subsidiary Earkart Inc. for American Market Expansion
Feb 26, 2026
More news about Earkart
14
Feb 26
Earkart Limited Secures ₹4.13 Crore Government Order from ALIMCO via GeM Portal
Earkart Limited has been awarded a government order worth ₹4,12,76,400 from ALIMCO through the GeM portal for supplying BTE hearing aids. The one-time domestic supply contract is expected to contribute positively to the company's revenue, with no related party transactions or promoter group interests involved.
14
Jan 26
Earkart Limited Secures ₹2.77 Crore Government Contract Through GeM Portal
Earkart Limited has been awarded a government contract worth ₹2.77 crores through the Government e-Marketplace (GeM) portal from Artificial Limbs Manufacturing Corporation of India (ALIMCO) for the supply of TLM Kits (LG95). The healthcare sector company made this disclosure on January 14, 2026, in compliance with SEBI regulations, confirming it as a one-time domestic supply contract with no related party transactions involved.
18
Dec 25
Earkart Board Reviews Turtle Maarks LLP Investment
Earkart Limited's board met on December 18, 2025, to discuss a potential investment in Turtle Maarks LLP. The board authorized a comprehensive review of the investment proposal, appointing an Independent Director to conduct fresh valuation and due diligence. Findings will be presented at the next board meeting on December 23, 2025, for final decision-making. The company has informed BSE Limited of this development in compliance with SEBI regulations.
09
Dec 25
Earkart Limited Reports Mixed H1 Results: Private Sector Growth Offsets Government Delays
Earkart Limited reported a 5% YoY revenue decline to ₹22.00 crores in H1 due to delayed government tenders. However, private sector growth of 25% partially offset the impact. The company secured ₹9.00 crores in new orders for H2 and aims to expand its OMNI audiometer installations from 56 to 110 clinics by March. Management expects a strong H2 performance to potentially compensate for the H1 shortfall.
20
Nov 25
Earkart Limited Secures ₹6.25 Crore Government Contract for Digital Hearing Aid Components
Earkart Limited has been awarded a ₹6.25 crore contract by the Government e-Marketplace (GeM) to supply 26,000 sets of components for BTE Digital Hearing Aid kits to ALIMCO, under the Ministry of Social Justice and Empowerment. The contract, awarded on November 19, is expected to positively impact the company's revenue. Earkart disclosed this information to BSE Limited on November 20, in compliance with SEBI regulations.
15
Nov 25
Earkart Limited Announces Board Decisions and Q2 FY2026 Results Post-IPO
Earkart Limited (BSE: 544549) held a board meeting on November 14, 2025, approving several important measures. The board authorized an ESOP scheme application, appointed N Kothari & Associates as Secretarial Auditor for FY 2025-26, and approved unaudited financial results for Q2 and H1 ending September 30, 2025. The company completed its IPO, issuing 3,315,000 equity shares at Rs 135 per share, increasing its paid-up capital to Rs 1,375.39 lakhs and generating a share premium of Rs 4,097.65 lakhs. Earkart has committed to transparency by ensuring timely disclosure of these developments to BSE Limited and making detailed financial results available on its website.
27
Oct 25
Earkart's OMNI Platform Showcased at Global Otolaryngology Conference
Earkart Limited presented its next-generation OMNI platform, a remote diagnostic solution for ENT care, at the world's largest otolaryngology conference in Indianapolis, USA. The event, attended by over 5,000 specialists from more than 75 countries, featured live demonstrations of OMNI's real-time diagnostics and remote consultation capabilities. The platform garnered significant interest from ENT specialists, audiologists, and healthcare leaders, suggesting potential for expansion across North America, Europe, the Middle East, and emerging healthcare markets. Earkart, a hearing healthcare solutions provider, operates with a business model combining technology, accessibility, and social impact, with a revenue split of 69% government and 29% private.
Earkart
122.
00
+
1.
00
(+
0.
83
%)
1 Year Returns:
-14.24%
Industry Peers
Poly Medicure
1,334.20
(+
3.
97
%)
Laxmi Dental
180.31
(+
1.
60
%)
Tarsons Products
181.63
(+
0.
97
%)
Osel Devices
515.25
(-
0.
04
%)
Vasa Denticity
373.00
(+
1.
72
%)
Fabtech Technologies
144.09
(+
1.
22
%)
Prevest Denpro
380.35
(+
5.
65
%)
Aprameya Engineering
211.20
(-
0.
71
%)
Hemant Surgical Industries
269.90
(+
5.
99
%)
Nureca
237.80
(+
4.
56
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO